Optimal Ranges
Clinical (NHS) Range
<75 nmol/L (low risk)
nmol/L
Performance-Optimised Range
<50 nmol/L (optimal)
nmol/L
The clinical range defines what is considered medically “normal” — broad enough to cover 95% of the population. The performance range reflects where research and clinical experience suggest most people feel and function at their best.
Why It Matters
Why Lp(a) matters for performance
Elevated Lp(a) is an independent, causal risk factor for atherosclerotic cardiovascular disease, aortic stenosis, and heart failure. The European Atherosclerosis Society recommends measuring Lp(a) at least once in every adult's lifetime because it's genetically fixed — if it's elevated, it's been elevated since birth, silently contributing to plaque buildup. Importantly, standard lipid panels (total cholesterol, LDL, HDL, triglycerides) don't capture Lp(a) at all. You could have a 'perfect' cholesterol panel and dangerously high Lp(a). Novel therapies targeting Lp(a) directly (antisense oligonucleotides like pelacarsen) are in Phase 3 clinical trials.
Symptoms
Signs your levels may be off
Low / Deficiency
- Low Lp(a) is protective — no adverse effects
High / Excess
- No direct symptoms — Lp(a) is a silent risk factor
- Premature cardiovascular disease (heart attack before age 55 in men)
- Family history of early heart disease
- Aortic valve calcification
- Increased stroke risk
Dietary Sources
Foods that support Lp(a) levels
Supplementation
Evidence-based supplementation
No supplement has been proven to meaningfully lower Lp(a). Niacin (vitamin B3) at pharmacological doses (1-3g) can reduce Lp(a) by 20-30%, but large trials (AIM-HIGH, HPS2-THRIVE) showed no clinical benefit and significant side effects. The focus for elevated Lp(a) should be: (1) Aggressively manage all other modifiable risk factors — keep LDL, ApoB, blood pressure, and HbA1c optimal. (2) Consider aspirin therapy if Lp(a) >50 nmol/L (discuss with GP). (3) Monitor for the arrival of targeted Lp(a)-lowering drugs (pelacarsen, olpasiran) currently in clinical trials. Know your number — it only needs to be tested once because it doesn't change.
Research
Key study
Lipoprotein(a) as a cardiovascular risk factor: current status
Tsimikas S, Fazio S, Ferdinand KC, et al.
European Heart Journal (2020)
DOI: 10.1093/eurheartj/ehz386Related Biomarkers
Related Guides
Test your Lp(a) levels
Lp(a) is included in the Helvy 50+ biomarker panel. Get your results in 5 days with a personalised protocol.
Order Your TestThis content is for educational purposes only and does not constitute medical advice. Your data suggests areas for optimisation, but any concerns should be discussed with a qualified healthcare professional. If your results flag values outside safe ranges, we recommend consulting your GP.